Anixa Biosciences
ANIX
ANIX
41 hedge funds and large institutions have $17.1M invested in Anixa Biosciences in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
9% less funds holding
Funds holding: 45 → 41 (-4)
38% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 8
Holders
41
Holding in Top 10
–
Calls
$99K
Puts
$64K
Top Buyers
| 1 | +$963K | |
| 2 | +$109K | |
| 3 | +$104K | |
| 4 |
Millennium Management
New York
|
+$83.7K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$80.1K |
Top Sellers
| 1 | -$141K | |
| 2 | -$61K | |
| 3 | -$56.3K | |
| 4 |
VF
Virtu Financial
New York
|
-$45K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$27K |